Two contrast agents currently in preclinical research are designed to attach to bacterial cell walls, allowing physicians to detect the bacteria when patients undergo imaging. Another imaging mechanism, called the Georgia Probe, can detect smaller bacteria than the two previously mentioned contrast agents. Although the contrast agents may be available for wide research soon, experts are unsure of how many researchers may be willing to invest in expensive imaging technology.
Read the report about contrast agents in imaging.
Related Articles on Infections:
Researchers Suggest Longer Blood Storage Could Increase Risk of Infections, Other Complications
Risk of Mortality, Longer Length of Stay Heightened Among Patients With Infections
State Officials Confirm Illinois Hospitals Improving Infection Rates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
